1Rouvier E,Luciani MF,Mattéi MG,et al. CTLA-8,cloned from an actiVated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpes virus saimiri gene[J]. J Immunol, 1993, 150(12): 5445-5456.
2Yao Z, Fanslow WC, Seldin MF, et al. Herpesvirus Saimiri encodes a new cytokine,IL-17,which binds to a novel cytokine receptor[J]. Immunity, 1995, 3(6): 811-821.
3Akhavanpoor M,Gleissner CA,Gorbatsch S,et al. CCL19 and CCL21 modulate the inflammatory milieu in ather-osclerotic lesions[J]. Drug Des Devel Ther, 2014, 8:2359-2371.
4Iwakura Y,Ishigame H,Saijo S, et al. Functional specialization of interleukin-17 family members[J]. Immunity, 2011, 34(2): 149-162.
5Iwakura Y,Ishigame H,Saijo S, et al. Functional specialization of interleukin-17 family members[J]. Immunity, 2011, 34(2): 149-162.
6Zhang B,Liu C,Qian W, et al. Crystal structure of IL-17 receptor B SEFIR domain[J]. J Immunol, 2013, 190 (5):2320-2326.
7Suzukawa M,Morita H, Nambu A,et al. Epithelial cell-derived IL-25, but not Th17 cell-derived IL-17 or IL-17F, is crucial for murine asthma[J].J Immunol, 2012, 189(7): 3641-3652.
8Ruddy MJ,Wong GC,Liu XK,et al. Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer-binding protein family members[J]. J Biol Chem,2004,279(4): 2559-2567.
9Schwandner R,Yamaguchi K,Cao Z. Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction[J]. J Exp Med,2000, 191(7): 1233-1240.
10Shen F,Li N,Gade P,et al. Kalvakolanu DV, IL-17 receptor signaling inhibits C/EBP beta by sequential phosphorylation of the regulatory 2 domain[J]. Sci Signal, 2009,2(59): ra8.
二级参考文献25
1Nguyen CQ, Hu MH, Li Y, et al. Salivary gland tissue ex- pression of interleukin-23 and interleukin-17 in Sjogren's syndrome: findings in humans and mice [ J . Arthritis Rheum ,2008,58 (3) :734.
2Su XM, Ye J, Hsueh EC, et al. Tumor microenvironments direct the recruitment and expansion of human Thl7 cells [ J ]. J Immuno1,2010,184 ( 3 ) : 1630.
3Yang ZZ, Novak A J, Ziesmer SC, et al. Malignant B cells skew the balance of regulatory T cells and TH17 cells in B- cell non-Hodgkin's lymphoma [ J ]. Cancer Res, 2009,69 (13) :5522.
4Renkonen J, Wolff H, Paavonen Y. Expression of cyclo-oxy- genase-2 in human tongue carcinoma and its precursor le- sions[ J]. Virchows Arch,2002,440(6) :594.
5Pandey M, Prakash O, Santhi WS, et al. Overexpression of COX-2gene in oral cancer is independent of stage of dis- ease and degree of differentiation[ J. lnt J Oral Maxillofac Surg,2008,37(4) :379.
6Sudha VM, Hemavathy S. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcino- ma : an immunohistochemical study [ J ]. Indian J Dent Res, 2011,22(4) :520.
7Hori S,Nomura T,Sakaguchi S.Control of regulatory T cell development by the transcription factor Foxp3. Science . 2003
8Ana Izcue,Sophie Hue,Sofia Buonocore,Carolina V. Arancibia-Cárcamo,Philip P. Ahern,Yoichiro Iwakura,Kevin J. Maloy,Fiona Powrie.Interleukin-23 Restrains Regulatory T Cell Activity to Drive T Cell-Dependent Colitis[J]. Immunity . 2008 (4)
9Alberto Mantovani,Pedro Romero,A Karolina Palucka,Francesco M Marincola.Tumour immunity: effector response to tumour and role of the microenvironment[J]. The Lancet . 2008 (9614)
10Nicolas Larmonier,Marilyn Marron,Yi Zeng,Jessica Cantrell,Angela Romanoski,Marjan Sepassi,Sylvia Thompson,Xinchun Chen,Samita Andreansky,Emmanuel Katsanis.Tumor-derived CD4+CD25+ regulatory T cell suppression of dendritic cell function involves TGF-β and IL-10[J]. Cancer Immunology, Immunotherapy . 2007 (1)
